C-reactive protein and natural IgM antibodies are activators of complement in a rat model of intestinal ischemia and reperfusion

Surgery

Volumn 142, Issue 5, 2007, Pages 722-733

  Padilla, Niubel Diaz ^a   van Vliet, Arlène K ^b   Schoots, Ivo G ^b   Seron, Mercedes Valls ^a   Maas, M Adrie ^b   Peltenburg, Esther E Posno ^b   de Vries, Annebeth ^b   Niessen, Hans W M ^c   Hack, C Erik ^a,c,d   van Gulik, Thomas M ^b  

^a SANQUIN RESEARCH   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CRUCELL HOLLAND BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4B; IMMUNOGLOBULIN M; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; HOMOGENATE; INTESTINE INJURY; INTESTINE ISCHEMIA; MALE; MESENTERIC ARTERY OCCLUSION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; REPERFUSION; STOMACH MUCOSA;

ANIMALS; C-REACTIVE PROTEIN; CAPILLARY PERMEABILITY; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C4B; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; INTESTINES; MALE; NEUTROPHILS; PEPTIDE FRAGMENTS; PHOSPHORYLCHOLINE; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 35548990501     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.05.015     Document Type: Article

References (46)

1. Grace P.A. Ischaemia-reperfusion injury. Br J Surg 81 (1994) 637-647
2. Collard C.D., Vakeva A., Morrissey M.A., Agah A., Rollins S.A., Reenstra W.R., et al. Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol 156 (2000) 1549-1556
3. Stahl G.L., Xu Y., Hao L., Miller M., Buras J.A., Fung M., et al. Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol 162 (2003) 449-455
4. Walsh M.C., Bourcier T., Takahashi K., Shi L., Busche M.N., Rother R.P., et al. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol 175 (2005) 541-546
5. Weiser M.R., Williams J.P., Moore Jr. F.D., Kobzik L., Ma M., Hechtman H.B., et al. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 183 (1996) 2343-2348
6. Ciurana C.L.F., and Hack C.E. Molecular mechanisms of complement activation during ischaemia and reperfusion. In: Vincent J.L. (Ed). Yearbook of intensive care and emergency medicine (2002), Springer, Berlin
7. Steel D.M., and Whitehead A.S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15 (1994) 81-88
8. de Beer F.C., Baltz M.L., Munn E.A., Feinstein A., Taylor J., Bruton C., et al. Isolation and characterization of C-reactive protein and serum amyloid P component in the rat. Immunology 45 (1982) 55-70
9. Mold C., Rodic-Polic B., and Du Clos T.W. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors. J Immunol 168 (2002) 6375-6381
10. Volanakis J.E., and Kaplan M.H. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med 136 (1971) 612-614
11. Chang M.K., Binder C.J., Torzewski M., and Witztum J.L. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci U S A 99 (2002) 13043-13048
12. Hack C.E., Wolbink G.J., Schalkwijk C., Speijer H., Hermens W.T., and van den Bosch H. A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. Immunol Today 18 (1997) 111-115
13. Braciale V., Der Balian G., and Davie J.M. Isoelectric focus analysis of rat anti-phosphocholine antibodies. Biochemistry 16 (1977) 5303-5308
14. Padilla N.D., Ciurana C., van Oers J., Ogilvie A.C., and Hack C.E. Levels of natural IgM antibodies against phosphorylcholine in healthy individuals and in patients undergoing isolated limb perfusion. J Immunol Methods 293 (2004) 1-11
15. Kim S.J., Gershov D., Ma X., Brot N., and Elkon K.B. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 196 (2002) 655-665
16. Wolbink G.J., Brouwer M.C., Buysmann S., ten Berge I.J., and Hack C.E. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J Immunol 157 (1996) 473-479
17. Diaz Padilla N., Bleeker W.K., Lubbers Y., Rigter G.M., Van Mierlo G.J., Daha M.R., et al. Rat C-reactive protein activates the autologous complement system. Immunology 109 (2003) 564-571
18. Krijnen P.A., Ciurana C., Cramer T., Hazes T., Meijer C.J., Visser C.A., et al. E. IgM colocalises with complement and C reactive protein in infarcted human myocardium. J Clin Pathol 58 (2005) 382-388
19. Griselli M., Herbert J., Hutchinson W.L., Taylor K.M., Sohail M., Krausz T., et al. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 190 (1999) 1733-1740
20. Yasuhara H. Acute mesenteric ischemia: the challenge of gastroenterology. Surg Today 35 (2005) 185-195
21. Arumugam T.V., Shiels I.A., Woodruff T.M., Granger D.N., and Taylor S.M. The role of the complement system in ischemia-reperfusion injury. Shock 21 (2004) 401-409
22. Wada K., Montalto M.C., and Stahl G.L. Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat. Gastroenterology 120 (2001) 126-133
23. Zhao H., Montalto M.C., Pfeiffer K.J., Hao L., and Stahl G.L. Murine model of gastrointestinal ischemia associated with complement-dependent injury. J Appl Physiol 93 (2002) 338-345
24. Hill J., Lindsay T.F., Ortiz F., Yeh C.G., Hechtman H.B., and Moore Jr. F.D. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol 149 (1992) 1723-1728
25. Eror A.T., Stojadinovic A., Starnes B.W., Makrides S.C., Tsokos G.C., and Shea-Donohue T. Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine. Clin Immunol 90 (1999) 266-275
26. Davis III A.E. Biological effects of C1 inhibitor. Drug News Perspect 17 (2004) 439-446
27. Karpel-Massler G., Fleming S.D., Kirschfink M., and Tsokos G.C. Human C1 esterase inhibitor attenuates murine mesenteric ischemia/reperfusion induced local organ injury. J Surg Res 115 (2003) 247-256
28. Schoots I.G., Levi M., Roossink E.H., Bijlsma P.B., and van Gulik T.M. Local intravascular coagulation and fibrin deposition on intestinal ischemia-reperfusion in rats. Surgery 133 (2003) 411-419
29. Park P.O., Haglund U., Bulkley G.B., and Falt K. The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. Surgery 107 (1990) 574-580
30. Krawisz J.E., Sharon P., and Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87 (1984) 1344-1350
31. Bos I.G., van Mierlo G.J., Bleeker W.K., Rigter G.M., te Velthuis H., Dickneite G., et al. The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model. Int Immunopharmacol 1 (2001) 1583-1595
32. de Smet B.J., de Boer J.P., Agterberg J., Rigter G., Bleeker W.K., and Hack C.E. Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats. Blood 81 (1993) 56-61
33. Vermeulen E.G., Niessen H.W., Bogels M., Stehouwer C.D., Rauwerda J.A., and van Hinsbergh V.W. Decreased smooth muscle cell/extracellular matrix ratio of media of femoral artery in patients with atherosclerosis and hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 21 (2001) 573-577
34. Austen Jr. W.G., Kobzik L., Carroll M.C., Hechtman H.B., and Moore Jr. F.D. The role of complement and natural antibody in intestinal ischemia-reperfusion injury. Int J Immunopathol Pharmacol 16 (2003) 1-8
35. Fleming S.D., Shea-Donohue T., Guthridge J.M., Kulik L., Waldschmidt T.J., Gipson M.G., et al. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol 169 (2002) 2126-2133
36. Williams J.P., Pechet T.T., Weiser M.R., Reid R., Kobzik L., Moore Jr. F.D., et al. Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 86 (1999) 938-942
37. Hart M.L., Ceonzo K.A., Shaffer L.A., Takahashi K., Rother R.P., Reenstra W.R., et al. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J Immunol 174 (2005) 6373-6380
38. Arnold J.N., Wormald M.R., Suter D.M., Radcliffe C.M., Harvey D.J., Dwek R.A., et al. Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin. J Biol Chem 280 (2005) 29080-29087
39. Zhang M., Takahashi T., Alicot E.M., Vorup-Jensen T., Kessler B., Thiel S., et al. Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J Immunol 177 (2006) 4727-4734
40. Binder C.J., and Silverman G.J. Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin Immunopathol 26 (2005) 385-404
41. Zhang M., Austen Jr. W.G., Chiu I., Alicot E.M., Hung R., Ma M., et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A 101 (2004) 3886-3891
42. Zhang M., Alicot E.M., Chiu I., Li J., Verna N., Vorup-Jensen T., et al. Identification of the target self-antigens in reperfusion injury. J Exp Med 203 (2006) 141-152
43. Chan R.K., Ding G., Verna N., Ibrahim S., Oakes S., Austen Jr. W.G., et al. IgM binding to injured tissue precedes complement activation during skeletal muscle ischemia-reperfusion. J Surg Res 122 (2004) 29-35
44. Cai S., and Davis III A.E. Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion. J Immunol 171 (2003) 4786-4791
45. Chan R.K., Ibrahim S.I., Takahashi K., Kwon E., McCormack M., Ezekowitz A., et al. The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusion. J Immunol 177 (2006) 8080-8085
46. Nielsen E.W., Waage C., Fure H., Brekke O.L., Sfyroera G., Lambris J.D., and Mollnes T.E. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement. Mol Immunol 44 (2007) 1819-1826